e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Translational studies in chronic lung diseases: from bedside to bench
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2013 abstract - Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks
M. Kumar, N. Weissman, W. Seeger, R. Voswinckel (Badnauheim, Giessen, Germany)
Source:
Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session:
Translational studies in chronic lung diseases: from bedside to bench
Session type:
Poster Discussion
Number:
244
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kumar, N. Weissman, W. Seeger, R. Voswinckel (Badnauheim, Giessen, Germany). LSC 2013 abstract - Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks. Eur Respir J 2013; 42: Suppl. 57, 244
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
DNA damage as a molecular link in the pathogenesis of COPD in smokers
Source: Eur Respir J 2012; 39: 1368-1376
Year: 2012
Novel compounds for WNT/ß-catenin induced lung repair in chronic obstructive pulmonary disease
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or being exposed to biomass
Source: Eur Respir J 2005; 26: Suppl. 49, 105s
Year: 2005
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
Dysregulation of serum miRNA in chronic obstructive pulmonary disease
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014
Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Self-efficacy. Does it change as a result of pulmonary rehabilitation? A pilot study
Source: Annual Congress 2006 - Effective strategies for chronic respiratory patient management
Year: 2006
Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept